BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 32157202)

  • 1. Application of miRNAs in the diagnosis and monitoring of testicular germ cell tumours.
    Almstrup K; Lobo J; Mørup N; Belge G; Rajpert-De Meyts E; Looijenga LHJ; Dieckmann KP
    Nat Rev Urol; 2020 Apr; 17(4):201-213. PubMed ID: 32157202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-371a-3p Serum Levels Are Increased in Recurrence of Testicular Germ Cell Tumor Patients.
    Terbuch A; Adiprasito JB; Stiegelbauer V; Seles M; Klec C; Pichler GP; Resel M; Posch F; Lembeck AL; Stöger H; Szkandera J; Pummer K; Bauernhofer T; Hutterer GC; Gerger A; Stotz M; Pichler M
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30321995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study.
    Dieckmann KP; Radtke A; Geczi L; Matthies C; Anheuser P; Eckardt U; Sommer J; Zengerling F; Trenti E; Pichler R; Belz H; Zastrow S; Winter A; Melchior S; Hammel J; Kranz J; Bolten M; Krege S; Haben B; Loidl W; Ruf CG; Heinzelbecker J; Heidenreich A; Cremers JF; Oing C; Hermanns T; Fankhauser CD; Gillessen S; Reichegger H; Cathomas R; Pichler M; Hentrich M; Eredics K; Lorch A; Wülfing C; Peine S; Wosniok W; Bokemeyer C; Belge G
    J Clin Oncol; 2019 Jun; 37(16):1412-1423. PubMed ID: 30875280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can germ cell neoplasia in situ be diagnosed by measuring serum levels of microRNA371a-3p?
    Radtke A; Cremers JF; Kliesch S; Riek S; Junker K; Mohamed SA; Anheuser P; Belge G; Dieckmann KP
    J Cancer Res Clin Oncol; 2017 Nov; 143(11):2383-2392. PubMed ID: 28819887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. microRNA-371a-3p as informative biomarker for the follow-up of testicular germ cell cancer patients.
    van Agthoven T; Eijkenboom WMH; Looijenga LHJ
    Cell Oncol (Dordr); 2017 Aug; 40(4):379-388. PubMed ID: 28612337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miRNAs for testicular germ cell tumours: Contemporary indications for diagnosis, surveillance and follow-up.
    Chavarriaga J; Hamilton RJ
    Andrology; 2023 May; 11(4):628-633. PubMed ID: 36373757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs in Testicular Germ Cell Tumors: The Teratoma Challenge.
    Yodkhunnatham N; Pandit K; Puri D; Yuen KL; Bagrodia A
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnostic value of immunohistochemistry and FISH for chromosome 12p in type Ⅱ testicular germ cell tumors].
    Shen Q; Rao Q; Yu B; Xia QY; Bao W; Lu ZF; Shi QL; Zhou XJ
    Zhonghua Nan Ke Xue; 2016 Aug; 22(8):692-697. PubMed ID: 29019224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-World Application of Pre-Orchiectomy miR-371a-3p Test in Testicular Germ Cell Tumor Management.
    Badia RR; Abe D; Wong D; Singla N; Savelyeva A; Chertack N; Woldu SL; Lotan Y; Mauck R; Ouyang D; Meng X; Lewis CM; Majmudar K; Jia L; Kapur P; Xu L; Frazier AL; Margulis V; Strand DW; Coleman N; Murray MJ; Amatruda JF; Lafin JT; Bagrodia A
    J Urol; 2021 Jan; 205(1):137-144. PubMed ID: 32856980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum Levels of MicroRNA miR-371a-3p: A Sensitive and Specific New Biomarker for Germ Cell Tumours.
    Dieckmann KP; Radtke A; Spiekermann M; Balks T; Matthies C; Becker P; Ruf C; Oing C; Oechsle K; Bokemeyer C; Hammel J; Melchior S; Wosniok W; Belge G
    Eur Urol; 2017 Feb; 71(2):213-220. PubMed ID: 27495845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The metastatic potential of seminomatous germ cell tumours is associated with a specific microRNA pattern.
    Ernst S; Heinzelmann J; Bohle RM; Weber G; Stöckle M; Junker K; Heinzelbecker J
    Andrology; 2020 Nov; 8(6):1687-1698. PubMed ID: 32530514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of Serum miR-371a-3p in Predicting Relapse on Surveillance in Patients with Clinical Stage I Testicular Germ Cell Cancer.
    Lobo J; Leão R; Gillis AJM; van den Berg A; Anson-Cartwright L; Atenafu EG; Kuhathaas K; Chung P; Hansen A; Bedard PL; Jewett MAS; Warde P; O'Malley M; Sweet J; Looijenga LHJ; Hamilton RJ
    Eur Urol Oncol; 2021 Jun; 4(3):483-491. PubMed ID: 33288479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs in Differentiation of Embryoid Bodies and the Teratoma Subtype of Testicular Cancer.
    Myklebust MP; Søviknes AM; Halvorsen OJ; Thor A; Dahl O; Ræder H
    Cancer Genomics Proteomics; 2022; 19(2):178-193. PubMed ID: 35181587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pipeline to quantify serum and cerebrospinal fluid microRNAs for diagnosis and detection of relapse in paediatric malignant germ-cell tumours.
    Murray MJ; Bell E; Raby KL; Rijlaarsdam MA; Gillis AJ; Looijenga LH; Brown H; Destenaves B; Nicholson JC; Coleman N
    Br J Cancer; 2016 Jan; 114(2):151-62. PubMed ID: 26671749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Germ cell tumour subtypes display differential expression of microRNA371a-3p.
    Vilela-Salgueiro B; Barros-Silva D; Lobo J; Costa AL; Guimarães R; Cantante M; Lopes P; Braga I; Oliveira J; Henrique R; Jerónimo C
    Philos Trans R Soc Lond B Biol Sci; 2018 Jun; 373(1748):. PubMed ID: 29685967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of miRNA in Testicular Cancer: Current Insights and Future Perspectives.
    Ditonno F; Franco A; Manfredi C; Fasanella D; Abate M; La Rocca R; Crocerossa F; Iossa V; Falagario UG; Cirillo L; Altieri VM; Di Mauro E; Crocetto F; Barone B; Cilio S; Pandolfo SD; Aveta A; Mirone V; Franzese CA; Arcaniolo D; Napolitano L
    Medicina (Kaunas); 2023 Nov; 59(11):. PubMed ID: 38004082
    [No Abstract]   [Full Text] [Related]  

  • 17. The Novel Biomarker of Germ Cell Tumours, Micro-RNA-371a-3p, Has a Very Rapid Decay in Patients with Clinical Stage 1.
    Radtke A; Hennig F; Ikogho R; Hammel J; Anheuser P; Wülfing C; Belge G; Dieckmann KP
    Urol Int; 2018; 100(4):470-475. PubMed ID: 29698973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating MicroRNAs for Detection of Germ Cell Tumours: A Narrative Review.
    Fankhauser CD; Nuño MM; Murray MJ; Frazier L; Bagrodia A
    Eur Urol Focus; 2022 May; 8(3):660-662. PubMed ID: 35537936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic markers for germ cell neoplasms: from placental-like alkaline phosphatase to micro-RNAs.
    Rajpert-De Meyts E; Nielsen JE; Skakkebaek NE; Almstrup K
    Folia Histochem Cytobiol; 2015; 53(3):177-88. PubMed ID: 26306513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers: IV: Current and Future Utilization of Molecular-Genetic Tests for Testicular Germ Cell Tumors.
    Looijenga LHJ; Van der Kwast TH; Grignon D; Egevad L; Kristiansen G; Kao CS; Idrees MT
    Am J Surg Pathol; 2020 Jul; 44(7):e66-e79. PubMed ID: 32205480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.